Company Overview - The registered capital of Tianjin TEDA Biomedical Engineering Company Limited is RMB 189.045 million[4]. - Tianjin TEDA Biomedical Engineering Company Limited was officially listed on the Hong Kong GEM on June 18, 2002, under stock code 8189[4]. - The company operates in two main business areas: biological composite fertilizers and elderly care services, focusing on the elderly population with disabilities and dementia[4]. Business Operations - The biological composite fertilizer business includes a range of products aimed at promoting balanced growth of various crops[4]. - The company has completed acquisitions to exclusively own EEG quantitative detection and analysis technology, collaborating with medical institutions for accurate diagnosis of neurological and psychological diseases[4]. - The company is involved in the operation and management of elderly care facilities across the country, integrating resources and providing management consulting services[4]. - The company has a 100% ownership in Guangdong Welfare Dragon Composite Fertilizer Co., Ltd., which focuses on R&D, production, and sales of biological composite fertilizers[5]. - The company also holds a 51% stake in Shandong Haides Fertilizer Co., Ltd., which is engaged in similar fertilizer activities[5]. - The company has established a research institute for soil conditioning and restoration, focusing on regional soil resource management[5]. - The company is expanding its elderly care services and health management through various subsidiaries, including Beijing Hongdi Elderly Investment Management Co., Ltd.[5]. Financial Performance - The company reported a revenue of RMB 351,898,000 for the year ended December 31, 2018, representing a year-on-year decrease of 6.39%[18]. - The gross profit for 2018 was RMB 1,707,000, a significant decline of 96.79% compared to the previous year[18]. - The gross margin for 2018 was 0.49%, down from the previous year's margin, indicating a challenging operational environment[18]. - The attributable loss to shareholders for 2018 was RMB 177,680,000, with a loss per share of RMB 9.58, an increase of 1,068.29% from the previous year's loss per share of RMB 0.82[18]. - Total assets as of December 31, 2018, were RMB 448,980,000, a decrease from RMB 707,878,000 in 2017[10]. - Total liabilities increased to RMB 157,312,000 in 2018 from RMB 133,078,000 in 2017[10]. - The total revenue for the year ended December 31, 2018, was RMB 351,897,658, a decrease of 6.39% compared to RMB 375,906,530 in 2017[29]. - The comprehensive gross profit for the year was RMB 1,706,855, with a gross margin of 0.49%, down from 14.15% in the previous year[29]. - The impairment loss on intangible assets recognized for the year was RMB 227,361,866, attributed to changes in the Chinese market and business strategy[31]. - Other income and net losses for the year amounted to RMB 3,680,687, a decrease from RMB 5,377,946 in 2017[34]. - Research and development expenses for the year were RMB 11,667,239, an increase of 25.53% from RMB 9,294,266 in 2017[34]. - The administrative expenses for the year were RMB 32,195,141, a decrease of 11.13% from RMB 36,227,996 in the previous year[34]. Research and Development - The company has strengthened its R&D efforts in collaboration with the Chinese Academy of Agricultural Sciences to develop new fertilizer products[16]. - The company has launched a new brainwave detection service and established a new detection point in Xiamen[16]. - The company has developed new fertilizer products, including active shell chitosan soluble fertilizer and microbial fertilizers, which have received widespread recognition from farmers[24]. - The company has increased R&D efforts in organic fertilizers, with microbial fertilizers currently accounting for only about 7% of total fertilizer usage in China, compared to nearly 50% in developed countries[24]. - The company is committed to enhancing its core competitiveness through a technology innovation system that integrates market orientation and academic research[22]. - The company has established strategic collaborations with leading research institutions to develop new fertilizer products that meet green agricultural needs[24]. Elderly Care Services - The company won 8 projects in the Shanghai public bidding for elderly care services, aiming to provide rehabilitation and group therapy for 1,000 elderly individuals[16]. - The company aims to develop a professional elderly care industry chain in collaboration with top institutions in Europe, focusing on care for the elderly with disabilities and dementia[22]. - The company’s elderly care services are positioned to serve a wide demographic, including youth and the elderly, addressing various health management needs[25]. - The company has established a joint venture in Shandong to promote the "Shui Fa Rui Fu Elderly Care" brand and provide consulting services in elderly care management[29]. - The company is actively involved in international cooperation in the elderly care sector, partnering with French organizations to enhance service quality and operational standards[98]. Corporate Governance - The company is focusing on enhancing its corporate governance and risk management systems in compliance with GEM listing rules[19]. - The board of directors and management have been deemed to operate in compliance with laws and regulations, ensuring the protection of shareholder interests[68]. - The supervisory board held four meetings during the reporting period to review financial reports and ensure compliance with corporate governance[67]. - The company aims to enhance its internal control systems and governance structure in the upcoming year[70]. - The company has a strong management team with diverse backgrounds in finance, law, and healthcare, enhancing its operational capabilities[93][94][98]. - The board consists of nine members, including three executive directors, three non-executive directors, and three independent non-executive directors, ensuring compliance with GEM listing rules[124]. - The independent non-executive directors have confirmed their independence according to GEM listing rules, ensuring a balanced approach to shareholder interests[131]. Environmental Responsibility - The group focuses on environmental protection, with no significant pollution issues in its operations related to elderly care and health services[174]. - The company has implemented effective waste management practices, ensuring all solid waste is comprehensively utilized[177]. - The company has implemented advanced production processes, including high tower granulation and drum granulation, to minimize energy consumption and pollutant generation[186]. - Compliance with various environmental standards includes COD levels not exceeding 350 mg/L and ammonia levels not exceeding 20 mg/L in wastewater treatment agreements[188]. - The company plans to continue enhancing its environmental protection measures and resource utilization efficiency in future operations[196].
泰达生物(08189) - 2018 - 年度财报